Social Inflation and Sidecar Decision in Professional Liability
Lexon Insurance writes lawyers professional liability and miscellaneous E&O. Its net reserves are $600M, and its surplus is $300M. Over the past three years, closed claim severity has increased 18% annually, while frequency has been flat. The actuarial central estimate for prior-year reserve development is $55M adverse, but the range extends to $95M adverse at the 90th percentile and $230M at the 99th percentile. The company has a $100M aggregate reinsurance treaty attaching at $40M, with one reinstatement. A new sidecar investor offers $120M of collateralized capacity for a 20% quota share of the 2025 accident year, ceding commission of 25%, and a profit commission of 50% after a 10% return. The CEO wants to grow the book by 15% to diversify, but the CRO warns that the reserve range is wide and the reinsurance treaty may be exhausted. The board is concerned about earnings volatility and rating agency scrutiny. The company has a $30M letter of credit facility and $25M of holding company cash. The CFO projects a 1-in-100 reserve deterioration of $230M gross, or $90M net after the aggregate treaty.
1. Evaluate the reserve risk and the adequacy of the aggregate reinsurance treaty under the adverse development scenarios.
Read the worked answer
The central adverse development of $55M is manageable: the treaty attaches at $40M, so it pays $15M and the company retains $40M, or 13.3% of $300M surplus. At the 90th percentile of $95M, the treaty pays $55M and the company still retains $40M. The treaty therefore caps retained adverse development at $40M for gross adverse development up to $140M, because the retention is $40M and the limit is $100M. At the 99th percentile of $230M, the treaty pays its $100M limit and the company retains $90M, or 30% of surplus, which matches the CFO projection. That is a material breach of most reasonable risk tolerances. The one reinstatement is important: if there is a second adverse development event or a cat loss, the cover may be exhausted. The 18% annual severity trend also means the central estimate could migrate toward the 90th percentile quickly. The treaty is adequate for moderate adverse development but not for the tail, and the company should not treat the $40M retention as a hard cap.
2. Evaluate the sidecar proposal and whether it addresses the reserve risk and growth plan.
Read the worked answer
The sidecar is a 20% quota share of the 2025 accident year, with $120M of collateralized capacity, a 25% ceding commission, and a 50% profit commission after a 10% return. It reduces net premium and new-business loss volatility, provides collateralized capacity, and can support growth without consuming as much surplus. However, it does not automatically cover prior-year reserve development. Unless the sidecar agreement explicitly includes adverse development cover or reserve relief, the $600M of net reserves and the $55M to $230M adverse range remain with Lexon. The profit commission aligns incentives but also means Lexon gives up half of favorable new-business results after the investor return. A 15% growth plan combined with a 20% sidecar cession produces roughly 12% net growth if the cession applies uniformly, but it does not reduce the tail reserve risk. I would approve the sidecar only if it includes a reserve cover or if a separate adverse development cover is purchased, and I would cap growth until the reserve range is narrowed.
3. Recommend a board decision and conditions.
Read the worked answer
I would recommend pausing the 15% growth plan until the reserve review is complete. The board should require a reserve study focused on the 90th and 99th percentile scenarios and a plan to strengthen reserves if the central estimate moves above $55M. It should buy additional aggregate reinsurance or adverse development cover above the existing $100M xs $40M treaty, because the 99th percentile leaves $90M net, or 30% of surplus. The sidecar can be approved for new business only with a reserve carve-out, collateral requirements, and a clear termination provision. The company should also use the $25M holding company cash and $30M letter of credit facility as liquidity backstops, not as capital. Finally, the board should set a formal risk tolerance for reserve development, such as a net retained adverse development limit of 15% of surplus, and require reporting against that limit quarterly.